Hustle Chicago Stair Climb raises $800K for respiratory health and lung cancer research
CHICAGO (WGN) — At 94 stories and more than 1,600 steps into the air, the Hustle has transcended what many still call the Hancock Tower for more than 20 years.
'We've done this crazy thing for the past 23 years and it's been freaking awesome,' said Steve Ferkau, a double-lung transplant recipient who is a constant presence at the Hustle Chicago Charity Stair Climb.
'I have cystic fibrosis and 25 years ago, I had a double lung transplant,' Ferkau said. 'My life was saved by a beautiful girl from Iowa. Her name was Kari.'
'My mom and dad didn't expect me to live beyond my teens and I'm 64-and-three-quarters,' Ferkau said. 'I never would have made it that far if it weren't for people like the people in the stairwells, events like this and money raised for research for problems I have.'
More than 2,000 people took part in this year's climb, raising close to $800,000 in the process.
'People are out there in the stairwells from all different walks of life,' said Alex Rodriguez, digital communications coordinator with the Respiratory Health Association. 'We have people who have had double lung transplants we have people whose kids live with asthma. We have people who are trying to advocate for clean air policies.
'Everything we do today is to make sure we have a brighter future tomorrow.'
Money raised at the event goes to respiratory health and lung cancer research, resources for long COVID and COVID-19 patients, and a program to get asthma rescue medications in Illinois Public Schools.
For more on the Respiratory Health Association and the Hustle Chicago Charity Stair Climb, visit their website online: https://resphealth.org/hustle-chicago-charity-stair-climb/
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Epoch Times
an hour ago
- Epoch Times
Healing Shingles Naturally: How East Meets West in Fighting Viral Pain and Brain Risk
Shingles, also known as herpes zoster, is a viral infection that causes a painful, blistering rash and often affects older adults or those with weakened immune systems. But since the COVID-19 pandemic, shingles has been appearing in unexpected age groups—raising new concerns about immunity, stress, and long-term health risks. Without timely treatment, this condition can lead to serious complications, including persistent nerve pain and even cognitive decline. In an episode of the 'Health 1+1' program, Jonathan Liu, a Canadian professor of Traditional Chinese Medicine, discussed both Western and TCM approaches to treating the infection, along with immune-boosting medicinal recipes that may help reduce the risk of shingles. The Importance of Early Treatment The primary treatment for shingles involves antiviral medications such as famciclovir or valacyclovir, which are typically taken orally. In more severe cases, intravenous acyclovir may be used, particularly in hospitalized or immunocompromised patients. Liu emphasized that early intervention is crucial. Ideally, antiviral therapy should begin before blisters appear. The medication works by suppressing viral replication rather than repairing tissue damage; therefore, starting treatment more than three days after the onset of blisters may significantly reduce their effectiveness.
Yahoo
2 hours ago
- Yahoo
Black Kids Are 5 Times More Likely to Get Severe COVID. Now Vaccines Are Being Cut.
The Trump administration has declared an end to COVID-19 vaccine recommendations for children and pregnant people, and health experts have a warning: This is a threat to Black communities. U.S. Health and Human Services Secretary Robert F. Kennedy Jr., who oversees the Centers for Disease Control and Prevention, announced the decision on May 27 and said vaccine guidance would now focus solely on adults over 65 and those with high-risk conditions, effective immediately. By June 3, Dr. Lakshmi Panagiotakopoulos stepped down from her role helping lead the agency's COVID-19 vaccine advisory group, saying she could no longer support decisions that put pregnant people and children at risk. Before the changes took effect, COVID-19 vaccines were recommended for anyone 6 months and older. Kennedy did not offer a scientific rationale for the new recommendations. For Black Americans, the policy shifts are more than bureaucratic changes, according to Oni Blackstock, a physician and founder of Health Justice, a racial and health equity consulting practice. 'These new guidelines don't exist in a vacuum,' she said. 'Limiting booster eligibility risks further compromising the already fragile health status of many Black Americans.' Black Americans are 1.5 times more likely to contract COVID-19 and four times more likely to be hospitalized, according to the Centers for Medicare & Medicaid Services. Research from the Center for Primary Care at Harvard Medical School found that Black children are more than five times as likely to die from the virus. An estimated 165,000 to 220,000 Black Americans have died from COVID-19, according to data compiled by the APM Research Lab. According to a 2023 report from the U.S. Census Bureau, nearly 32% of Black Americans who contracted COVID-19 also experienced long COVID symptoms. The U.S. Food and Drug Administration cited a lack of evidence that annual boosters are needed by healthy, low-risk adults. However, Blackstock, a primary care and HIV physician, said the policy change marks a significant departure from past years when vaccines were broadly recommended and federally funded. 'This contradicts recent CDC data showing that the 2024–2025 boosters benefit people 18 years and older, especially early after vaccination,' she added. Blackstock noted that many Black Americans already struggle with health care access due to systemic barriers like a lack of insurance and residential segregation. 'When these combine with more restrictive vaccine guidelines,' she said, 'it becomes even harder for Black Americans to get boosters and worsens existing health disparities.' These barriers also deepen historic mistrust in health care, said Jerry Abraham, a family and community medicine physician. Abraham, who is director of the CDU-KEDREN Mobile Street Medicine program in Los Angeles, said the history of medical racism and continued treatment disparities fuel skepticism toward public health. Even as boosters offer real benefits, he said, many remain hesitant or disconnected from resources that ensure protection. 'If children and pregnant women are no longer recommended for vaccination, will grandma still go to CVS and get it herself?' he said. Abraham added that in an era where health care professionals can no longer trust the updated guidelines from federal agencies, it's deeply concerning and a reminder that Black communities must once again rely on themselves. For answers about what comes next, read on. Aisha Harris, a family medicine physician in Flint, Michigan, told Capital B that limiting access to COVID-19 vaccines for healthy adults exposes high-risk groups like seniors and those who are immunocompromised. 'Reduced protection in healthy people increases their risk of being infected by COVID and of being a carrier,' said Harris, who owns the direct primary care clinic Harris Family Medicine. 'When more people are contagious, with or without symptoms, they have a higher chance of infecting others around them, including in their household or those they are taking care of as caregivers.' She warned this undermines community immunity. Without widespread coverage, even eligible groups face elevated risks. FDA officials say the new approach mirrors those taken by Australia and several European nations that limit vaccines to older or high-risk adults. But some critics argue the shift ignores U.S. disparities and bypasses standard CDC procedures. You can pay out of pocket, but it could cost up to $200. If the CDC doesn't recommend vaccines, Abraham said health plans are much less likely to cover them, since insurers typically follow CDC guidance. Yes, COVID-19 vaccines have already undergone extensive clinical trials before being authorized for public use. The FDA says it will require longer clinical trials before approving updated shots for healthy kids and adults, with studies lasting at least six months, likely delaying fall approvals. The CDC's vaccine advisory committee is expected to vote on fall vaccine recommendations in late June, but it's unclear how much influence it will have over the newly announced changes. High-risk conditions for COVID-19 vaccine eligibility generally include chronic kidney disease, chronic lung diseases, asthma, diabetes, immunocompromised states (from cancer treatment, organ transplant, HIV, etc.), heart conditions, Alzheimer's disease, obesity, sickle cell disease, smoking, and stroke or cerebrovascular disease. Yes. Studies show COVID-19 vaccination, including boosters, reduces the risk of severe illness and may lower the chances of developing long COVID symptoms after infection. The post Black Kids Are 5 Times More Likely to Get Severe COVID. Now Vaccines Are Being Cut. appeared first on Capital B News.
Yahoo
3 hours ago
- Yahoo
After decimal error cost Florida $5M in COVID vendor deal, company agrees to repay state
A South Florida health care company that was overpaid millions by the state for a COVID-related contract is going to pay the state back. Trinity Health Care Services, which was contracted by the state to register people for COVID-19 vaccinations, recently settled a lawsuit filed against it by the Florida Division of Emergency Management, court records show. Trinity agreed to pay the agency $5,624,659.43 over the next several years. But it's going to do so in installments. According to the lawsuit, filed in Leon County and settled April 9, FDEM entered into a contract with Trinity for $50,578.50 in 2021, but the agency instead paid the company $5,057,850 to Trinity – an overage of five million bucks. At the time the contract was signed, the CEO was Sheila Cherfilus-McCormick, now a member of Congress and the subject of an unrelated House ethics complaint. Edwin Cherfilus, who was the CEO of Trinity at the time of the lawsuit and is now the vice president of operations, is the congresswoman's brother. Requests for comment for both the state and Trinity are pending with spokespeople. As previously reported, the state argued that Trinity, as a contractor, "was required to return any overpayments of invoices for work not actually performed and money not actually owed." According to the invoices attached to the lawsuit, many were submitted and paid in 2021. The letter to Trinity demanding repayment, however, was dated June 13, 2024. Trinity denied the allegations and the two parties agreed to settle the lawsuit to avoid the cost of future litigation. The company agreed to pay: $25,000 on or before April 18, 2025. $25,000 on or before May 8, 2025. $92,910.99 on or before Jan. 2, 2026. $92,910.99 on or before the first day of each quarter thereafter for 15 years until the settlement amount is paid in full. More: Florida files COVID-19 related suit after accidentally overpaying company $5 million Ana Goñi-Lessan, based in Tallahassee, is State Watchdog Reporter for USA TODAY - Florida. She can be reached at AGoniLessan@ This article originally appeared on Tallahassee Democrat: State settles after $5M overpayment on $50K COVID contract
